Tuesday November 24, 2009 12:32 AM ET
-
Bank Notes | College Planning | Debt | Elder Care | Employment | Estate Planning | Health Care | Insurance | Marriage & Divorce | Real Estate | Retirement | Taxes
-
Net Asset Value:
119.851-Day Return:
1.24 (1.05%)YTD Return
as of 11/23/09:
as of 11/23/09:
18.21%VGHCX
(Vanguard Health Care;Inv)
Classification: GL Health/Biotechnology
Objective: GL Health/Biotech
Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 18.21 | 38.66 | 0.76 | 6.39 | 8.90 |
| Classification | 18.44 | 36.67 | -1.32 | 3.71 | 5.10 |
| Index (S&P 500) | 25.20 | 41.80 | -5.60 | 0.80 | -0.60 |
| % Rank in Class (1-best,100=worst) | 61 | 31 | 28 | 9 | 7 |
| Investment Objective: | GL Health/Biotech |
|---|---|
| Net Assets ($Mil) | 10,976.20 |
| Inception Date: | 5/23/84 |
| Manager Name, Tenure | Owens/Hynes, 1984 / 2008 |
| Expense Ratio: | 0.29% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
Advertisements
Hear our feeds on Jott
Post/View comments about this fund
SmartMoney Mobile | Customer Service | Magazine Customer Service | Subscribe to SmartMoney Magazine | Your Profile | Contact Us
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
You Are Viewing: SmartMoney.com — Investing, Saving and Personal Finance.
